Q2 FY26 results swing to profit; board shelves planned fund raising
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Organics posted Q2 FY26 standalone revenue of Rs 157.21 cr against Rs 160.18 cr a year ago, but net profit was Rs 5.60 cr versus a loss of Rs 11.16 cr. H1 FY26 revenue rose to Rs 361.61 cr (vs Rs 328.09 cr) with PAT of Rs 13.17 cr versus a loss of Rs 11.60 cr. Consolidated H1 PAT was Rs 13.86 cr against a prior-year loss of Rs 13.09 cr. Board shelved its earlier fund raising proposal after arranging funding through banks. Ten officers were added to the Senior Management Personnel list.
Sharp swing to profitability lifts sentiment; shelved fund raise trims near-term dilution risk for shareholders.